ACTA2 and posterior cortical atrophy: Taken together, these results show that more advanced PCa samples with a higher Gleason score or metastasis stage have lower levels of expression of two SM markers (ACTA2 and CNN1), indicating either a reduction in the number of SMCs or the expression of these genes is decreased in the remaining cells.